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ABSTRACT 
Health economics is a relatively new but growing field 
within the discipline of economics and is concerned with 
making the best use of scarce resources. Early health 
economic estimates of new medical devices, in particular, 
can assist producers of health technology in making 
appropriate product design and investment decisions. It 
allows companies to understand their likely market and 
possible reimbursement more thoroughly. Despite the many 
advantages of point-of-care testing the key problem facing 
decision makers at the moment is the poor understanding of 
the potential value gained from new or alternative product 
or service offerings.  Understanding medical device features 
in the wider market place can be addressed used agent 
based modelling and simulation (ABMS).  In this paper we 
examine the use of ABMS underpinned by a novel data-
driven approach to model generation.  A sepsis use case is 
presented where pathway and device characteristics are 
defined using the ‘headroom’ method and a semantic 
evidence capture application.  Types and sub-types are 
automatically extracted into agent models and subsequently 
executed in our own data-driven agent based simulation 
platform (TEASIM).  A highly typed data-driven approach 
is evaluated in a manner that clearly presents the technical 
aspects of TEASIM platform and its practical usage. Initial 
evaluation of a data-driven approach (and the TEASIM 
platform) is positive. The approach offers a viable guide to 
product development in a cost-effective manner, especially 
in the earlier stages when deciding between potential 
product configurations or features. 
Author Keywords 
Health economic assessment, agent based modelling and 
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ACM Classification Keywords 
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1. INTRODUCTION 
Health technologies continue to make a substantial 
contribution to improving the health status of populations 
[1]. Nonetheless, OECD countries over a period of 10 years 
have witnessed an annual average health expenditure 
growth per capita of 4%, outpacing economic growth of 
2.2% during the same period [2].  A consequence of this is 
that health systems are faced with an economic problem 
and continually looking to achieve more for less economic 
cost.   The medical device industry and device developers 
have an important part to play in ensuring that efficiencies 
are achieved through increased efficiency of spending, and 
not at the expense of the quality of care received by patients 
[3]. One solution would be to enhance the decision maker 
understanding of the medical device decision domain and 
subsequent quality of go/no-go product development 
choices by incorporating health economic assessments in 
such decision-making processes [3,4,5]. The economic 
evaluation of public health interventions, in essence, 
provides a capability to maximize population health subject 
to scarce resources [6,7]. This makes it especially important 
and relevant to diagnostic services and Point-of-Care (PoC) 
technologies [8].  This is typically carried out  
The PoC diagnostic sector, which is a growing market, 
creates a challenging evaluative scenario because, on the 
one hand, the unit cost-per-test is larger through the loss of 
the economies of scale offered by automation, whilst it 
offers the potential of substantial savings through enabling 
rapid delivery of results, and reduction of facility costs [9]. 
In this context, allowing PoC builders to quickly design 
increasingly ‘realistic’ representations of what the product 
should do with a reasonable reimbursement price is not 
only a critical area of research but also a challenging one 
due to the fact that the properties of PoC devices closely 
interrelate with varied technical and non-technical 
healthcare information needs.  Knowledge platforms are 
able to support the collection and synthesis of healthcare 
information supporting economic evaluation - typically 
using aggregate measures and population data.  Coupling 
knowledge platforms with agent modelling provide decision 
makers with a novel combination of device re-imbursement 
and system impact analysis.   
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Adopting a design-science paradigm, with an emphasis on 
problem-solving, we introduce a number of innovative 
artefacts in order to design novel data-driven decision-
making tools - aimed at improving the early health 
economic evaluations of PoC devices and their subsequent 
usage. Artefacts are built as part of a design-build-evaluate 
cycle towards an effective solution and as theoretical 
knowledge is accumulated.  The paper presents two design-
build-evaluation cycles that result in knowledge (Tea-
PoCT) and agent modelling (Tea-Sim) platforms for early 
health economic evaluations by PoC device manufacturers. 
Importantly, the transition from knowledge platform to 
agent model is a primary focus in this paper. The structure 
of the paper is as follows: Section 2 presents work related 
to our efforts in economic evaluation and agent based 
modelling. In Section 3 our knowledge capture and 
annotation approach is detailed. Section 4 presents agent 
modeling driven by the knowledge platform. Section 5 
presents an evaluation of the resulting design artefacts, 
conclusions and opportunities for future work. 
2. BACKGROUND 
Health Economics is a relatively new but growing field 
within the discipline of economics and is concerned with 
making the best use of scarce resources [10-12]. It has been 
an established feature of research, policymaking, practice 
and management in the delivery of healthcare [[9] and its 
role is increasing as the cost of healthcare begins to drive 
changes in most major healthcare systems. Economic 
modelling, simulation and scenario analysis are tools that 
help decision makers make choices in a rational fashion 
[13]. This emerging area has consequently become the 
focus of both public policy and private sector transactions 
with associated input and output, input being healthcare 
spending and output being improved outcomes for patients 
[14,15]. A relevant case for health economics is the 
National Health Service (NHS) in the UK as it has been 
acknowledged that increases in NHS spending were not 
being accompanied by markedly improved outcomes [16]. 
Consider the NHS, ‘Health Economic’ evaluation offers 
decision-makers the tools to maximize output relative to a 
fixed budget input. 
Value assessment for medical products is a complex task 
and developing products or investing in this sector can be a 
daunting process [17,18]. If the ultimate goal of health-
economic evaluation of medical interventions is to support 
evidence-based policy decisions, then it is essential to place 
new products in terms of cost and effectiveness, relative to 
the current gold standard treatment [3]. 
The ‘Headroom method’ is used to assess the cost-
effectiveness of a new technology in comparison to some 
existing gold standard technology, by defining a maximum 
cost (the Headroom) that the adopter of the technology 
would be willing to incur [19]. Technologies or projects 
whose cost exceeds the maximum Headroom can be 
deemed cost-ineffective and abandoned. On the other hand, 
technologies whose costs fall below the Headroom are not 
necessarily going to be cost-effective, but they show 
potential for adoption, which can be decided at later stages 
of the cost-effectiveness assessment. Therefore, the method 
can be used as a barrier to unsustainable projects at early 
stages, or even before their commencement [20]. The 
Headroom method offers a simple way for manufacturers to 
investigate the commercial viability of a new medical 
device, by applying the principles of health economic 
evaluation early on, ideally at the concept stage [20]. 
Clinical data verifying effectiveness is apparently absent at 
this stage, but the innovator's ideas around what the device 
could mean for patients (impact on health) and the NHS 
(cost impact for services) can be used to estimate its 
reimbursement prospects. Thus, the method uses early 
predictions of potential impact (which should be optimistic 
but plausible) to estimate what the NHS should be willing 
to pay for the device if it works as hoped. In short, the 
Headroom method can be explained as follows: [20] 
Agent based modelling (ABM) has been applied in a 
number of domains including economics [21], health-care 
[22], and geography [23] among others. ABM also has links 
with other disciplines including social sciences, artificial 
life science, management science and complexity science 
[24,25]. A resurgence in interest in ABM likely benefits 
from the most recent development in the Artificial 
Intelligence (AI), and Individual Based Modelling (IBM) in 
ecology. More traditionally, ABM has been applied to 
cellular automata to investigate housing segregation 
patterns by modelling people and the socially relevant 
process, which represent interactions between people [26]. 
In business, agent-based modelling has been applied to help 
decision makers understand underlying market structures 
and anticipate dynamics in the market place [25]. 
Simulations can help clarify uncertainty by identifying the 
causes of the market dynamics. 
ABM is often a process comprising analysis, design, 
implementation, execution and validation [27]. State charts 
often underpin the ABM approach and more specifically an 
understanding of environmental and agent state [28] – 
typically investigating the expenses associated with a 
healthcare setting. State machine inputs, outputs and 
probabilistic state transition drive the executing simulation 
[29]. ABM in healthcare has traditionally been motivated 
by the analysis and construction of models [28] that rely 
heavily on domain experts for their construction. In 
contrast, relying purely on the data generated by a real-
world health systems is more ambitious.  However, the 
growth in open data is providing a means to uncover 
insights from this type of novel approach.    Emergency 
departments have been a popular area to investigate, better 
understanding the modelling required [27] and subsequent 
optimization [29].  Synthesizing the economic modelling 
with agent approaches (especially for medical device 
manufacturers) has had less coverage in the literature. 
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3. LANGUAGE, STYLE AND CONTENT 
The design problem being addressed is accessibility to data 
and decision making tools for the medical device 
manufacturers.  Our data-driven simulation design response 
combines a knowledge capture platform with agent based 
simulation.  The remainder of this section describes the first 
three steps before focusing on the agent modelling in the 
following section. 
 
Figure 1. Data-driven Simulation Framework 
The remainder of this section describes the first three steps 
before focusing on the agent modelling in the following 
section. 
3.1 Knowledge Capture Platform 
We use a Sepsis scenario to demonstrate our approach. 
Initially, a first data model is created, recording Sepsis facts 
on our Tea-PoCT platform. MediaWiki software was 
extended to support visual and semantic tagging and hosted 
at www.Tea-PoCT.com. MediaWiki (or Wiki technology) 
was chosen at it offers functionality to store several 
revisions of the same file, made by different users, and 
provides a place to store and validate emerging evidence. 
Secondly, it provides a basis by which an analyst can turn 
validated information residing in the wiki into structured 
information for later use. MediaWiki is also a full-fledged 
development framework (PHP), with available extensions 
(i.e. semantic MediaWiki, html tags) that can turn a wiki 
into a powerful and flexible knowledge management 
system. All data created within Tea-PoCT can then be 
accessible on the Semantic Web, allowing other 
applications to use this data seamlessly (due in part to the 
self-describing nature of the platform). Figure 2 shows two 
snapshots of the Tea-PoCT wiki, one from the main page 
and one from the Sepsis page. 
 
Figure 2. Snapshots of the Tea-PoCT MediaWiki 
To provide accessible and consumable data for platform 
services and PoC device manufacturers, an extractor was 
developed for accessing wiki stored clinical data. The aim 
of the extractor is to harvest the ‘semantically annotated 
data’ ready for the agent platform or other external services. 
Semantically annotated data is able to be read and 
understood not only by human but also by machines. The 
main point in creating semantically annotated data is 
enabling applications to search, retrieve and process the 
content in a more intelligent way. Authorised clients can 
then download this data into the Agent platform, Excel 
spreadsheet or Web based economic modelling for device 
specific analysis.  
Once the Tea-PoCT platform became available, an 
extensive literature review was undertaken to collect data 
about the clinical area under investigation.  
3.2 Knowledge Gathering 
Currently the key problem facing PoC decision makers is 
lack of access to good evidence and clear cases concerning 
product or service data. A comprehensive literature review 
is therefore needed to identify product data sources and to 
summarize the existing evidences on four clinical areas 
being explored (Sepsis). Sepsis is one of the most expensive 
conditions that can affect patients. In the UK alone, the 
Sepsis Trust puts NHS spending linked to the condition at 
£2.5 billion (NCEPOD, 2014). The diagnosis of this 
condition is quite complicated as it appears like a range of 
other medical conditions in its early stages. For clinicians 
that have seen Sepsis develop before, they may be able to 
diagnose it with successful treatment during the early 
stages. Nevertheless, for clinicians without prior direct 
experience with Sepsis, the diagnosis is more problematic. 
Although Health Economic (HE) basics are relatively easy 
to grasp, accessing quality data quickly, is however 
problematic. Data will often not exist – especially if the 
product is novel and so appropriate data must be inferred 
from the literature, elicited from experts or even estimated. 
Once identified, product and service data is semantically 
annotated and compiled into Tea-PoCT using ‘PicTags’ (or 
picture tags). PicTags are small icons that have a unique 
name, associated data (e.g. cost, price and charge), links 
and sematic annotation. With the help of PicTags the key 
names and values can be differentiated from the 
surrounding text and can be identified and extracted 
through semantic mechanisms and queries. Figure 3 
illustrates the semantically annotated data in our 
MediaWiki system. In addition, MediaWiki was extended 
to provide a secure means of safeguarding the data from 
unauthorized access. Accordingly, unauthenticated users 
(i.e. public view) cannot read or understand the 
semantically annotated data that are crucial for cost-
effectiveness analysis. 
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Figure 3. Semantically annotated data with pictags 
Once data is captured and semantically annotated, 
economic and scenario modelling can be carried out.  
3.3 Knowledge Gathering 
At this stage an economic model was constructed within 
Tea-PoCT, based on the Headroom method, in order to 
explore various Sepsis cost-effectiveness scenarios. The 
economic model was developed in such a way as to 
evaluate and predict the cost-effectiveness of PoC devices 
with specific functionalities, quality-adjusted life years 
(QALYs) and the Headroom over time periods up to 6 
years, which can be extended as required. The rationale is 
to allow decision maker to interact with the data directly 
and to explore different development consequences. We 
believed that this approach would further help PoC 
developers to attain a better understanding of the early 
health economic evaluations and the challenges they might 
face. Unsurprisingly, this same data can be easily utilized 
uncovering agents and their behaviors. Furthermore, 
interested parties are able join the Tea-PoCT project and 
provide further input into the modelling and to make the 
prediction and economic assessments even more fine-
grained. In our economic model the Headroom is 
formulated as follows: 
MRP = P2 = WTP threshold x ∆QALY - ∆SC + P1 
Where: 
 MRP = Maximum reimbursable price 
 P2 = The maximum price the manufacturer can 
charge for the new device (= MRP) 
 WTP threshold = Pre-determined QALY tariff 
between £20,000 and £30,000 per patient 
 ΔQALY = Increments in effectiveness between the 
new device and the gold standard, measured in 
QALYs. ΔQALY = (utility score of treatment B x 
duration (years) of that health state) - (utility score 
of treatment A x duration (years) of that health 
state) 
 ΔSC = Decrements or savings in service costs due 
to the new more effective device. ΔSC = Cost of 
Treatment B (New tech) – Cost of Treatment A 
(Old/Gold standard) 
 P1 = The price of the old device (if it exists)  
  
Figure 4. Scenario Analysis 
Figure 4 represents different characteristics of a PoC 
device, allowing the user to change the highlighted fields 
and experience different cost-effectiveness and 
development scenarios. The headroom method is 
implemented within the wiki page alongside scenario 
specifications.  Tables and graphical results are also defined 
(again as pictags) and presented within the page.  Scenarios 
can be tested to fully understand the economic implications 
of a medical device and its usage. Now that the device 
manufacturer understands the economic impact of the 
device, the same data can then be used for simulating it use 
in the healthcare environment. 
4. AGENT MODELLING 
The next design challenge was how best to reuse the 
captured and validated data within a simulation 
environment – extracting appropriate pictag data of value.  
Our first design instantiation (presented in this paper) 
focuses on the agent modelling paradigm.  A number of 
agent modelling environments exist, but tend to be either 
graphical based, where the user builds a model inside the 
tool, or programming language based.  In contrast, with a 
rich data repository it was decided to explore how the agent 
model could more easily be driven by the data itself. 
Underpinning our simulation approach is a relational model 
with tables as agent types and rows represented agent 
instances.  This approach enables nuanced variation of 
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agent properties (e.g. age) without the need to define a new 
agent. The executing simulator user JSON files (extracted 
from a relational model, Tea-PoCT or hand-crafted) to 
specify agents and behaviors. This form of modelling 
enables decision makers to gain additional insight into a 
complex system behavior and to demonstrate the real 
situation of a sepsis patient in a hospital. A simulation is 
constructed from available Tea-PoCT pathway or economic 
data. The simulation is designed to determine the estimated 
cost of sepsis patient based on their condition and the 
duration of stay at the hospital.   Our data-driven simulation 
platform is called Tea-Sim and implemented in PHP with 
supporting JSON files.  Both file types can be generated 
from Tea-PoCT (or other data sources such as relational 
databases). PHP configuration, agents and agent behavior 
can make use of Tea-PoCT data to further explore medical 
device within a health context, e.g. cost impact to a 
hospital.  We have developed a proof of concept model in 
this paper, but envisage that the same approach can be 
extended to apply the same medical device economics in a 
more specific hospital, area or country. 
Our hospital environment requires a number of agents to be 
implemented:  
A critical_patient of class people,  
Anot_critical_patient of class people,  
A dead_patient of class people,  
A normal_patient of class people and  
A nurse of class people.  
In our Tea-Sim platform, each agent is denoted by specific 
id and set of variables. The agent variables are listed below: 
$this->_supertype 
$this->_type 
$this->_id 
$this->_img 
$step 
These variables are accessible to the step functions, 
including the pointer to a visual representation of the 
current agents state (_img). Agent behavior is then 
implemented in a number of available functions, such as: 
getPosition() 
move($distance) 
anyNeighbour($distance[,$type[,$select[,$update]]]) 
allNeighbour($distance[,$type[,$select[,$update]]]) 
morph($type) 
In order to set up the sepsis simulation, two files are 
required for initialization and model execution - init.json 
and model.json. JSON file are used as these are easily 
processed and generated from the Tea-PoCT platform. The 
init.json file determines the initialization processing to be 
carried out. Grid size, number of instances for each agent, 
the position of each agent and the simulation steps are 
defined in init.json. Agent attributes of class people are 
defined in model.json with behaviour (step functions) in 
steps.php. 
 
 
Figure 5. critical_patient of class people agent 
 
 
 Figure 6. not_critical_patient of class people 
 
Agent behavior specification is described in a module 
called steps.php. The stepping function, step() describes 
how each agent of a specific type progresses from one 
iteration to another, including state changes. In steps.php, 
the health processes or internal rules are being processed. 
Figure 5 show the rules applied to critical_patient of class 
people agent and figure 6 shows the rules applied to 
not_critical_patient of class people agent.  
The processes provided in steps.php describe agent actions, 
such as: 
i. If nurse is not near the not_critical_patient, then make 
yes/no decision to become critical_patient or 
not_critical_patient 
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i.i. If (not_critical_patient is still not_critical_patient), 
check if nurse is around 
i.i.i. If YES (nurse is around), not_critical_patient become 
normal_patient,  
Probabilistically determine the length of stay in general 
ward and calculate cost 
i.i.ii. If NO (nurse is not around), not_critical_patient 
become critical_patient  
i.ii. If (not_critical_patient is now critical_patient), check if 
nurse is around 
i.ii.i. If YES (nurse is around), probabilistically determine 
the length of stay in intensive care unit (ICU) and 
associated calculate cost 
i.ii.ii. If NO (nurse is not around and steps is more or equal 
than 9), critical_patient become dead_patient and store the 
total number of days and cost 
ii. If nurse is not near or near the critical_patient,  
ii.i. If YES (nurse is around), critical_patient become 
not_critical_patient, probabilistically determine the length 
of stay in ICU ward and calculate cost 
ii.ii. If NO (nurse is not around and steps is more or equal 
than 9), critical_patient become dead_patient and store the 
total number of days and cost 
 
Executing simulations can be seen in figures 7-9. 
 
 
Figure 7. Sepsis Simulation with three types of agent, 
critical_patient, not_critical_patient and nurse  
 
Figure 7 shows when agent of nurse (blue box) is near 
agent of critical_patient and agent of not_critical patient it 
will change the critical_patient to not_critical_patient 
(green box) and the not_critical_patient to normal_patient 
and the cost will be calculated (Figure 8).  Although we are 
using simple colored blocks, any image can be used in the 
simulation with additional state annotation as an option. 
  
Figure 8. critical_patient become not_critical_patient and 
not_critical_patient become normal_patient with calculated cost 
and number of days in ward 
In a further simulation, Figure 9, the agent nurse is not near 
agent critical_patient after the mortality rate reaches 80% 
or more, critical_patient become dead_patient (black box) 
 
  
Figure 9. critical_patient become dead_patient after 
mortality reaches 80% or more 
5 EVALUATION AND CONCLUSION 
Tea-PoCT and Tea-Sim provide users with the methods, 
framework and evidence, or simply the basis for making 
early estimates, through a set of innovative hosted digital 
services. Tea-PoCT is the first phase of a vision where 
product and service providers are better connected to 
patients and near patient practitioners. While the purpose of 
evaluation in the project’s initial phase was to assess the 
feasibility and effectiveness of the idea of the Tea-PoCT’s 
extended MediaWiki system and the process of data 
acquisition and economic modelling, the aim of the 
subsequent design iteration evaluates the utility of 
economic data to the simulation process. The instantiation 
of a number of simulations demonstrates the viability of the 
approach.  Furthermore, it was clear that data can be easily 
re-used in a wider simulation, specifically: 1) Variations of 
disease, 2) Disease Burden, i.e. mortality rate of 8%/hour 
and 3) Economic burden and cost in terms of duration and 
finance. 
This research also opens a number of future research 
avenues, stimulating improvement in existent processes and 
further lead to designed advances. It is envisaged that the 
platform proposed in this paper can further evolve and 
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support research into novel client decision-making apps, 
mobile apps and collaborative economic modelling. 
Originality in Tea-PoCT and Tea-Sim can also be seen in 
the bringing together of elements of knowledge seeking and 
acquisition, modelling and simulation. In addition, a further 
contribution for the platform in use will be a state of the art 
medical data vault populated with real world product and 
service offerings and importantly the associated simulations 
and scenarios.   
Design science is underpinned by the artefacts produced 
over the course of a design journey, categorized by March 
and Smith [30] as constructs, models, methods and 
instantiations.  This paper presented a rich set of artefacts, 
each combining as part of an effective design.  Constructs 
such as pictags provide a means for much of the knowledge 
identification and re-use.  Data models for each disease 
utilize the technological methods – pictags, extractors, 
agent code – to drive the agent based simulation models.  
Tea-PoCT and Tea-Sim instantiations demonstrate the 
effectiveness of these artefacts and the overall designed 
approach. 
The paper provides a practical insight into how data can 
drive both the economic modelling of medical devices and 
their impact on a heath environment.  Two design research 
instantiations are presented – a knowledge acquisition tool 
Tea-PoCT and agent based simulator Tea-Sim.  A sepsis 
scenario demonstrates how economic modelling data 
acquisition can be re-used in an agent based simulation. 
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